Document ID: chunk:federal_register_of_legislation:F2025C00214:clause:1_61612
Version: federal_register_of_legislation:F2025C00214
Segment Type: clause
Provision Reference: sch 1 cl 61612
Character Range: 317876–318812

61612                                Whole body FDG PET study for the initial staging of eligible cancer types, for a patient who is considered suitable for active therapy, if:                                                                                                                                                                                                                                                   953.00
                                     (a) the eligible cancer type is:
                                     (i) a rare or uncommon cancer (less than 12 cases per 100,000 persons per year); and
                                     (ii) a typically FDG‑avid cancer; and
                                     (b) there is at least a 10% likelihood that the PET study result will inform a significant change in management for the patient
                                     Applicable once per cancer diagnosis (R)